Need for validation of clinical decision aids: Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C

American Journal of Gastroenterology

Volumn 95, Issue 9, 2000, Pages 2328-2332

  Imperiale, Thomas F ^a,b   Said, Areen T ^a   Cummings, Oscar W ^a   Born, Lawrence J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BIOPSY; CROSS-SECTIONAL STUDIES; DECISION MAKING; DECISION SUPPORT TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 0033834092     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)01114-X     Document Type: Article

References (23)

1. Clinical prediction rules. A review and suggested modifications of methodological standards
2. Statistical approaches too development and validation of predictive instruments
3. The SGOT/SGPT ratio - An indicator of alcoholic liver disease
4. SGOT/SGPT ratios
5. Elevated SGOT/SGPT ratio in alcoholic patients with acetaminophen hepatotoxicity
6. The serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase ratio as a prognostic index in severe acute viral hepatitis
7. Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty infiltration in morbidly obese patients
8. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
9. AST/ALT ratio ≥1 is not diagnostic of cirrhosis in patients with chronic hepatitis C
10. Histological classification and quantification of the severity of chronic hepatitis: Keeping it simple!
11. Transection of the oesophagus for bleeding esophageal varices
12. The importance of disease prevalence in transporting clinical prediction rules: The case of streptococcal pharyngitis
13. Predicting clinical states in individual patients
14. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis
15. Clinical prediction rules. Applications and methodological standards
16. Assessing the generalizability of prognostic information
17. Why predictive indexes perform less well in validation studies. Is it magic or methods?
18. Therapy of hepatitis C: Patients with cirrhosis
19. Prognosis of chronic hepatitis C: Results of a large prospective cohort study
20. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment
21. Efficacy of interferon treatment for patients with chronic hepatitis C; comparison of response in cirrhotics, fibrotics, or nonfibrotics
22. Interferon α-2b alone or in combination with ribavirin as initial therapy for chronic hepatitis C
23. Randomized trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)